Cannabis Report
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

PSTI RSS Feed
Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: n3m3sis
Search This Board: 
Last Post: 7/20/2018 11:24:53 PM - Followers: 166 - Board type: Free - Posts Today: 0

 

Pluristem Therapeutics Inc. (Nasdaq: PSTI) 

 

 

http://www.pluristem.com/

 

 


 

Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com

 

CIK:  0001158780

 

Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 

 

Management: 

http://www.pluristem.com/index.php/about2/management.html
 

Clinical Program: 

http://www.pluristem.com/index.php/clinic-program.html


Recent News and Press:

http://www.pluristem.com/index.php/press-room.html

http://finance.yahoo.com/q/h?s=PSTI+Headlines

http://seekingalpha.com/symbol/PSTI

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001158780&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


 

 

 

Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501

 

Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
karinek@pluristem.com


 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

Cannabis Report
PSTI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific 07/09/2018 07:00:00 AM
PSTI News: Pluristem and Fukushima University Report Positive Data: PLX-R18 Increases Survival Rates and Mitigates Severe Intestinal Dam... 06/25/2018 07:00:00 AM
PSTI News: U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries 06/19/2018 07:00:00 AM
PSTI News: Pluristem to Open Weekly Market Trading at TASE Following Positive Study Results 06/14/2018 07:00:00 AM
PSTI News: Current Report Filing (8-k) 06/12/2018 04:00:44 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#8104  Sticky Note All PSTI Board Posters - For Clarification. n3m3sis 11/10/17 08:11:05 AM
#13940   The conditioned medium of human mesenchymal stromal cells FDApproved 07/20/18 11:24:53 PM
#13939   Blue.....Is Your Resume Ready ? FDApproved 07/20/18 06:17:08 PM
#13938   Pluristem Issues Letter to Shareholders. FDApproved 07/20/18 05:55:11 PM
#13937   Mesenchymal stem/stromal cells as a delivery platform in FDApproved 07/20/18 05:20:41 PM
#13936   You Will Never Know Why We Love It FDApproved 07/20/18 05:08:40 PM
#13934   Right-On Brother Gary ! We Be Happy Some FDApproved 07/20/18 04:49:40 PM
#13932   I've seen all sorts of speculation here, everything skitahoe 07/20/18 04:34:40 PM
#13931   I Find This Very Intriguing ! FDApproved 07/20/18 04:06:16 PM
#13930   Well the good news is PSTI has ZERO EichKing 07/20/18 03:58:28 PM
#13929   Excellent comparison... Auto1 07/20/18 03:02:23 PM
#13927   zzatt, please Auto1 07/20/18 02:17:26 PM
#13926   Get back to filling prescriptions before you get zzaatt 07/20/18 02:14:43 PM
#13925   Think we'll see Auto1 07/20/18 02:11:52 PM
#13924   Hopester...IMO..The Main Reason Auto1 07/20/18 02:06:55 PM
#13920   Spideyboy, thanks for reiterating and expanding on the zzaatt 07/20/18 01:32:08 PM
#13919   I can see how people might think along Spideyboy 07/20/18 01:06:40 PM
#13918   So you've been stuck in it for a zzaatt 07/20/18 01:00:05 PM
#13917   $1.30 is all one needs to know....hope(less)ster warned zzaatt 07/20/18 12:52:13 PM
#13916   Hopester...IMO..The Main Reason The Stock Is Has Been FDApproved 07/20/18 12:50:27 PM
#13914   So you've been stuck in it for a hopester 07/20/18 12:41:39 PM
#13913   $1.30 is all one needs to know....be VERY EichKing 07/20/18 12:40:36 PM
#13912   Umpteen yearsI'm not able to interpret that (and zzaatt 07/20/18 12:34:04 PM
#13911   POTENTIAL!!! hopester 07/20/18 12:29:19 PM
#13910   You are spot on recognizing that competition is zzaatt 07/20/18 12:25:44 PM
#13909   Potential starts at the starting line. Umpteen years hopester 07/20/18 12:24:29 PM
#13908   First there is no share value to crushThere zzaatt 07/20/18 12:20:36 PM
#13907   You are spot on recognizing that competition is hopester 07/20/18 12:20:05 PM
#13906   Well then why is the stock $1.29This seems zzaatt 07/20/18 12:14:54 PM
#13905   Well then why is the stock $1.29 for hopester 07/20/18 12:05:43 PM
#13904   my view is the overriding fear that a zzaatt 07/20/18 12:05:37 PM
#13903   MMBO...The Only Way Big Pharma Can Beat PSTI FDApproved 07/20/18 11:40:31 AM
#13902   May I offer: EichKing 07/20/18 11:36:55 AM
#13901   I have been reading this board for a mmbo 07/20/18 11:03:11 AM
#13900   PSTI (DEAD MONEY) has been nothing but a EichKing 07/20/18 10:29:56 AM
#13898   Hi Mikems, thanks for the link. zzaatt 07/20/18 09:53:26 AM
#13897   POTENTIAL....... that's all there is. zzaatt 07/20/18 09:48:40 AM
#13896   Competition ( Novartis with deep pockets ) looms zzaatt 07/20/18 09:37:53 AM
#13895   POTENTIAL....... that's all there is. hopester 07/20/18 09:32:32 AM
#13894   There is absolutely ZERO chance this will zzaatt 07/20/18 09:17:32 AM
#13893   Competition ( Novartis with deep pockets ) looms hopester 07/20/18 08:49:18 AM
#13892   Novartis sticks its own breakthrough in acute radiation syndrome FDApproved 07/20/18 08:36:19 AM
#13891   That's unfortunate and explains a great deal. hopester 07/20/18 06:58:42 AM
#13889   Medical Market Research mentions Pluristem as one of Mikems 07/20/18 03:08:18 AM
#13888   Yeah, sure. The science, or promise there EichKing 07/20/18 12:25:15 AM
#13886   Wouldn't be shocked if next year this time kiki27 07/20/18 12:11:48 AM
#13885   IMO..This Study Supports One Of Pluristem's MoA Of FDApproved 07/20/18 12:02:56 AM
#13883   Like I have said.....for months on end.....PSTI is zzaatt 07/19/18 08:55:29 PM
#13880   TECHNICAL ANALYSIS AS I POINTED OUT TO YOU zzaatt 07/19/18 07:31:17 PM
#13879   I'm not ready to write it off just hopester 07/19/18 06:50:46 PM
#13878   Well......that is a wrap for this week. EichKing 07/19/18 05:42:09 PM
PostSubject